MA27170A1 - Preparation combinee de l'inhibiteur d'echange sodium-hydrogene cariporide avec des inhibiteurs de l'enzyme de conversion pour prevenir l'insuffisance cardiaque et d'autres dysfonctionnements organiques lies a l'age, des affections liees a l'age et pour prolonger la vie - Google Patents

Preparation combinee de l'inhibiteur d'echange sodium-hydrogene cariporide avec des inhibiteurs de l'enzyme de conversion pour prevenir l'insuffisance cardiaque et d'autres dysfonctionnements organiques lies a l'age, des affections liees a l'age et pour prolonger la vie

Info

Publication number
MA27170A1
MA27170A1 MA27801A MA27801A MA27170A1 MA 27170 A1 MA27170 A1 MA 27170A1 MA 27801 A MA27801 A MA 27801A MA 27801 A MA27801 A MA 27801A MA 27170 A1 MA27170 A1 MA 27170A1
Authority
MA
Morocco
Prior art keywords
age
cariporide
sodium
hydrogen
heart failure
Prior art date
Application number
MA27801A
Other languages
English (en)
Inventor
Wolfgang Linz
Ursula Schindler
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of MA27170A1 publication Critical patent/MA27170A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MA27801A 2002-02-04 2004-07-27 Preparation combinee de l'inhibiteur d'echange sodium-hydrogene cariporide avec des inhibiteurs de l'enzyme de conversion pour prevenir l'insuffisance cardiaque et d'autres dysfonctionnements organiques lies a l'age, des affections liees a l'age et pour prolonger la vie MA27170A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10204571 2002-02-04

Publications (1)

Publication Number Publication Date
MA27170A1 true MA27170A1 (fr) 2005-01-03

Family

ID=27674558

Family Applications (1)

Application Number Title Priority Date Filing Date
MA27801A MA27170A1 (fr) 2002-02-04 2004-07-27 Preparation combinee de l'inhibiteur d'echange sodium-hydrogene cariporide avec des inhibiteurs de l'enzyme de conversion pour prevenir l'insuffisance cardiaque et d'autres dysfonctionnements organiques lies a l'age, des affections liees a l'age et pour prolonger la vie

Country Status (23)

Country Link
EP (1) EP1474134B1 (fr)
JP (1) JP4733348B2 (fr)
KR (1) KR20040083498A (fr)
CN (1) CN1319528C (fr)
AR (1) AR038387A1 (fr)
AT (1) ATE520398T1 (fr)
AU (1) AU2003244430A1 (fr)
BR (1) BR0307443A (fr)
CA (1) CA2474888A1 (fr)
CO (1) CO5601009A2 (fr)
HR (1) HRP20040702A2 (fr)
HU (1) HUP0402593A2 (fr)
MA (1) MA27170A1 (fr)
MX (1) MXPA04007569A (fr)
NO (1) NO20043698L (fr)
NZ (1) NZ534479A (fr)
PE (1) PE20040188A1 (fr)
PL (1) PL370488A1 (fr)
RS (1) RS68204A (fr)
RU (1) RU2004126702A (fr)
TW (1) TW200306850A (fr)
WO (1) WO2003066045A1 (fr)
ZA (1) ZA200406066B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG184353A1 (en) * 2010-03-31 2012-11-29 Hospital For Sick Children Use of remote ischemic conditioning to improve outcome after myocardial infarction

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0855392A3 (fr) * 1997-01-22 2000-01-05 Hoechst Aktiengesellschaft Hétérocycles à cinq chaínons contenant des substituants biphénylylsulphoniques, leur procédé de préparation, leur utilisation comme médicament ou agent diagnostique ainsi que médicament les contenant
DE19734693A1 (de) * 1997-08-11 1998-01-22 Hoechst Marion Roussel De Gmbh Verwendung von Cariporide als Inhibitor des zellulären NA+/H+-Exchangers (NHE) zur Herstellung eines Medikaments zur Behandlung von cardialen und nichtcardialen Krankheiten
DE19737224A1 (de) * 1997-08-27 1999-03-18 Hoechst Marion Roussel De Gmbh Pharmazeutisches Kombinationspräparat aus einem Inhibitor des Natrium-Wasserstoff-Austauschers und einem Arzneimittel zur Behandlung von Herz-Kreislauferkrankungen
US6011059A (en) * 1997-12-24 2000-01-04 Bristol-Myers Squibb Company Acyl guanidine sodium/proton exchange inhibitors and method
DE19859727A1 (de) * 1998-12-23 2000-06-29 Aventis Pharma Gmbh Die Verwendung von Hemmern des Natrium-Wasserstoff-Austauschers zur Herstellung eines Medikaments zur Verhinderung von altersbedingten Organ-Dysfunktionen, altersbedingten Erkrankungen zur Lebensverlängerung

Also Published As

Publication number Publication date
JP4733348B2 (ja) 2011-07-27
AR038387A1 (es) 2005-01-12
RU2004126702A (ru) 2005-04-20
JP2005519072A (ja) 2005-06-30
EP1474134A1 (fr) 2004-11-10
WO2003066045A1 (fr) 2003-08-14
CA2474888A1 (fr) 2003-08-14
CN1694697A (zh) 2005-11-09
NZ534479A (en) 2006-03-31
MXPA04007569A (es) 2004-11-01
RS68204A (sr) 2007-02-05
NO20043698L (no) 2004-08-31
CN1319528C (zh) 2007-06-06
PE20040188A1 (es) 2004-05-17
ZA200406066B (en) 2005-06-08
PL370488A1 (en) 2005-05-30
BR0307443A (pt) 2005-01-04
HRP20040702A2 (en) 2005-04-30
TW200306850A (en) 2003-12-01
ATE520398T1 (de) 2011-09-15
KR20040083498A (ko) 2004-10-02
EP1474134B1 (fr) 2011-08-17
CO5601009A2 (es) 2006-01-31
AU2003244430A1 (en) 2003-09-02
HUP0402593A2 (hu) 2005-04-28

Similar Documents

Publication Publication Date Title
TW200607553A (en) Mass or energy transfer cartridge and module
BR0313371A (pt) Composto, uso de um composto e método de tratamento de doença
WO2006029319A3 (fr) Modulation de l'activite de la phosphatase dans des cellules cardiaques
EP1480521A4 (fr) Myelinisation de prosencephales congenitalement demyelinises par utilisation de cellules souches d'oligodendrocyte
UY28103A1 (es) Nuevas imidazo-piridinonas sustituidas, su preparación y su empleo como medicacmentos
TR200201668T2 (tr) Vla-4' e bağlı hücre bağlamasının peptidilsiz önleyicileri
WO2007147782A3 (fr) Oximesulfonates et utilisation de ceux-ci en tant qu'acides latents
WO2004044003A3 (fr) Utilisation du recepteur de edg-2 dans un modele animal d'insuffisance cardiaque
WO2001030781A3 (fr) Inhibiteurs d'adhesion cellulaire induite par alphalbeta¿2?
EA200200301A1 (ru) ЗАМЕЩЕННЫЕ α-ГИДРОКСИКИСЛОТЫ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, СПОСОБ ИНГИБИРОВАНИЯ КЛЕТОЧНОЙ ГИБЕЛИ НА КЛЕТОЧНОМ ИЛИ ТКАНЕВОМ УРОВНЕ, СПОСОБ ЛЕЧЕНИЯ ИЛИ ОБЛЕГЧЕНИЯ СОСТОЯНИЯ ПРИ ГИБЕЛИ КЛЕТОК У ЖИВОТНОГО, СПОСОБ ЛЕЧЕНИЯ ИЛИ ПРОФИЛАКТИКИ РАЗЛИЧНЫХ БОЛЕЗНЕЙ
NO995114L (no) Festeanordning for å forbinde to deler med hverandre, samt anvendelse av festeanordningen
HRP20080027T3 (hr) 4-hidroksi-4-metil-piperidin-1-karboksilna kiselina (4-metoksi-7-morfolin-4-il-benzotiazol-2-il)-amid
BR9907746A (pt) ácidos 2,3,4,5-tetraidro-1h[1,4]-benzodiazepina-3-hidroxâmic os como inibidores de matriz de metaloproteinase
RU2002107079A (ru) Вещество, обладающее седативным действием
USD479281S1 (en) Board game for teaching DNA concepts
ID30351A (id) Derivatip-derivatip 2,3-0-isopropylidene monosakarida sebagai penghambat perekatan sel
BRPI0415034A (pt) derivados de aminopiridina como inibidores de não-sintase induzìveis
ATE262507T1 (de) Substituierte n-phenyl-2-hydroxy-2-methyl-3,3,3- trifluorpropanamid-derivative zur erhöhung der pyruvatdehydrogenaseaktivität
SK9042001A3 (en) The utilisation of inhibitors of the sodium hydrogen exchanger for producing a medicament for preventing organ dysfunctions and diseases related to a particular age and for prolonging life
WO2006066778A3 (fr) Heteroarylacetamides
SE0401540D0 (sv) New compounds
ATA7862002A (de) Wasserauslaufbatterie
NZ534479A (en) Combination preparation of the sodium-hydrogen exchange inhibitor cariporide with ACE inhibitors for preventing heart failure and other age-related dysfunctions of organs, age-related diseases and for prolonging lifespan
GB0227007D0 (en) Scaffolds useful to the synthesis of compounds with biological activity
TH30036S1 (th) นาฬิกาข้อมือ